| Financial Year |
March 31 2023 |
| Monetary Funds |
632,836,565.85 |
| Held-for-trading Financial Assets |
465,761,204.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
138,661,445.93 |
| Advances to Suppliers |
41,247,949.92 |
| Other Receivables |
21,636,249.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
118,850,336.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,481,823.96 |
| Total Current Assets |
1,430,475,575.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,744,544.72 |
| Investment Properties |
-- |
| Fixed Assetes |
12,094,420.98 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
178,856.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,363,514.29 |
| Deferred Income Tax Assets |
2,653,369.41 |
| Other Non-Current Assets |
1,799,631.96 |
| Sub-Total of Non-Current Assets |
132,787,239.28 |
| Total Assets |
1,563,262,815.24 |
| Short-Term Loans |
1,753,357.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,862,708.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,902,998.10 |
| Taxes Payable |
5,737,442.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,535,986.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,997,730.52 |
| Other Current Liabilities |
520,993.77 |
| Sub-Total of Current Liabilities |
103,142,163.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,382,843.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,809,650.62 |
| Total Liabilities |
132,951,814.20 |
| Paid-In Capital(Or Share Stock) |
66,666,667.00 |
| Capital Surplus |
973,858,460.56 |
| Surplus Reserve |
42,786,902.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
332,039,901.34 |
| Minority Stockholder's Interest |
14,959,069.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,415,351,931.79 |
| Owner's Equity（Stockholder's Equity） |
1,430,311,001.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,563,262,815.24 |
